Get started
Author

Sonia Brugnara

Observed names: S Brugnara, S. Brugnara
ORCID: 0000-0002-6464-007X
Observed ORCID: 0000-0002-6464-007X
OpenAlex ID: A5059772546
Cisplatin, Dacarbazine With or Without Subcutaneous Interleukin-2, and Interferon Alfa-2b in Advanced Melanoma Outpatients: Results From an Italian Multicenter Phase III Randomized Clinical Trial
2002 · Ruggero Ridolfi, Vanna Chiarion-Sileni, et al. · Journal of Clinical Oncology · 134
M‐CAM expression as marker of poor prognosis in epithelial ovarian cancer
2006 · Daniela Aldovini, Francesca Demichelis, et al. · International Journal of Cancer · 92
Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study
2021 · M. Guida, S. Strippoli, et al. · ESMO Open · 61
PDF
Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens
2011 · for the Italian Melanoma Intergroup (IMI), V Chiarion-Sileni, et al. · British Journal of Cancer · 56
PDF
Multiple Rechallenges for Castration-resistant Prostate Cancer Patients Responding to First-line Docetaxel: Assessment of Clinical Outcomes and Predictive Factors
2012 · Orazio Caffo, Giovanni Pappagallo, et al. · Urology · 53
Concurrent adjuvant chemotherapy and immediate breast reconstruction with skin expanders after mastectomy for breast cancer
2000 · Orazio Caffo, Daniela Cazzolli, et al. · Breast Cancer Research and Treatment · 53
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup
2023 · Marco Rubatto, Paolo Fava, et al. · European Journal of Cancer · 23
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma
2024 · M. Caccese, I. Desideri, et al. · ESMO Open · 21
PDF
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort
2019 · Cristina Pellegrini, Francesca Botta, et al. · The Lancet Child & Adolescent Health · 21
PDF
Treatment with combined dabrafenib and trametinib in BRAFV600E-mutated metastatic malignant melanoma: a case of long-term complete response after treatment cessation
2018 · Sonia Brugnara, Mariacristina Sicher, et al. · Drugs in Context · 13
PDF
Onset of vitiligo following targeted therapy for BRAFV600E-mutated melanoma: case report
2019 · Sonia Brugnara, Mariacristina Sicher, et al. · Drugs in Context · 7
PDF
Temozolomide (TMZ) as prophylaxis for melanoma brain metastases (BrM): Results from a phase III, multicenter study
2008 · V. Chiarion-Sileni, M. Guida, et al. · Journal of Clinical Oncology · 6
G48A, a New KRAS Mutation Found in Lung Adenocarcinoma
2016 · Mirko Marabese, Elisa Caiola, et al. · Journal of Thoracic Oncology · 5
High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors
2025 · Michele Guida, Benedetta Apollonio, et al. · Journal of Translational Medicine · 3
PDF
Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single centre
2017 · Mariachiara Dipasquale, Viviana Murgia, et al. · Anti-Cancer Drugs · 2
507MO REGOMA-OS: A large Italian multicenter, prospective, observational study analyzing regorafenib efficacy and safety in recurrent glioblastoma patients
2023 · G. Lombardi, I. Desideri, et al. · Annals of Oncology · 1
P01.084 Re-irradiation in recurrent glioblastoma: proton therapy with or without chemotherapy
2018 · D Amelio, D Scartoni, et al. · Neuro-Oncology · 1
Proton Therapy Reirradiation in Difficult-to-Treat Recurrent Glioblastoma
2017 · D. Amelio, D. Scartoni, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Concurrent chemoradiotherapy (cCTRT) with weekly cisplatin (wCDDP) in locally advanced cervical cancer (LACC) patients (pts): a monoinstitutional experience
2015 · V. Murgia, O. Caffo, et al. · Annals of Oncology · 1
Weekly paclitaxel (wPCT) for pretreated patients (pts) with advanced non-small cell lung cancer (aNSCLC): Updated data from a single institution experience in the daily clinical practice.
2014 · Mariachiara Dipasquale, Orazio Caffo, et al. · Journal of Clinical Oncology · 1
Pain after quadrantectomy and radiotherapy (QUART) for early-stage breast cancer (BC): incidence, characteristics and influence on quality of life (QL). Results from a retrospective study
2001 · M. Amichetti, O. Caffo, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
Caregiver professional employment and its impact on glioblastoma patient survival: Results from two prospective studies.
2026 · Vincenzo Di Nunno, Alicia Tosoni, et al. · Journal of Clinical Oncology
PDF
Financial toxicity, Socioeconomic Status, and clinical outcome in Glioblastoma: the ISES-2 Prospective Multicenter Italian Study
2026 · Alicia Tosoni, Laura Arenare, et al. · SSRN Electronic Journal
Ctni-39. Regoma-os: a Large Italian Multicenter, Prospective, Observational Study Analyzing Regorafenib Efficacy and Safety in Recurrent Glioblastoma Patients
2023 · Mario Caccese, Isacco Desideri, et al. · Neuro-Oncology
PDF
P17.07.a Regorafenib in Recurrent Glioblastoma Patients: an Italian Observational, Multicentric and Prospective Trial (regoma-oss)
2023 · M Caccese, M Padovan, et al. · Neuro-Oncology
PDF
Works count: 55
Citation count: 556
H-index: 10
I10-index: 10
Year
Topic
Type